Rajendra Nath

931 total citations
58 papers, 650 citations indexed

About

Rajendra Nath is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Rajendra Nath has authored 58 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Complementary and alternative medicine and 8 papers in Pharmacology. Recurrent topics in Rajendra Nath's work include Natural Antidiabetic Agents Studies (8 papers), Computational Drug Discovery Methods (6 papers) and Phytochemicals and Medicinal Plants (5 papers). Rajendra Nath is often cited by papers focused on Natural Antidiabetic Agents Studies (8 papers), Computational Drug Discovery Methods (6 papers) and Phytochemicals and Medicinal Plants (5 papers). Rajendra Nath collaborates with scholars based in India, United Arab Emirates and Australia. Rajendra Nath's co-authors include Rishi Pal, Prafulla Tiwari, Bhargava Kp, Kamlesh Kumar Pant, Nidhi Singh, Rakesh Dixit, Manisha Gupta, G.P. Gupta, M.B. Gupta and Seema R. Pathak and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Pharmacology and Psychopharmacology.

In The Last Decade

Rajendra Nath

53 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rajendra Nath India 16 175 162 87 69 62 58 650
Mahmoud Balbaa Egypt 14 196 1.1× 88 0.5× 47 0.5× 67 1.0× 54 0.9× 47 605
Lohanathan Bharathi Priya Taiwan 15 213 1.2× 109 0.7× 79 0.9× 63 0.9× 53 0.9× 18 642
Rainer Ziegenhagen Germany 6 156 0.9× 62 0.4× 50 0.6× 71 1.0× 57 0.9× 17 591
Shiva Roshankhah Iran 17 215 1.2× 160 1.0× 123 1.4× 137 2.0× 119 1.9× 78 847
G. Smilin Bell Aseervatham India 10 134 0.8× 83 0.5× 110 1.3× 65 0.9× 47 0.8× 12 523
Ashfaq Ahmad Malaysia 16 153 0.9× 91 0.6× 153 1.8× 68 1.0× 67 1.1× 58 876
T. Balakrishna Poduval India 13 297 1.7× 80 0.5× 57 0.7× 44 0.6× 51 0.8× 28 706
Fatma Göçer Türkiye 12 136 0.8× 96 0.6× 147 1.7× 94 1.4× 78 1.3× 19 567
Incoronata Laurenza Italy 8 177 1.0× 88 0.5× 46 0.5× 77 1.1× 122 2.0× 8 437
P. L. Vijayammal India 15 231 1.3× 94 0.6× 210 2.4× 98 1.4× 32 0.5× 27 754

Countries citing papers authored by Rajendra Nath

Since Specialization
Citations

This map shows the geographic impact of Rajendra Nath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajendra Nath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajendra Nath more than expected).

Fields of papers citing papers by Rajendra Nath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajendra Nath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajendra Nath. The network helps show where Rajendra Nath may publish in the future.

Co-authorship network of co-authors of Rajendra Nath

This figure shows the co-authorship network connecting the top 25 collaborators of Rajendra Nath. A scholar is included among the top collaborators of Rajendra Nath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajendra Nath. Rajendra Nath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pal, Rishi, et al.. (2023). Neuroprotective role of chloroquine via modulation of autophagy and neuroinflammation in MPTP-induced Parkinson’s disease. Inflammopharmacology. 31(2). 927–941. 9 indexed citations
2.
Tiwari, Prafulla, et al.. (2023). Role of Nitric Oxide Modulators in Neuroprotective Effects of Mangiferin in 6-Hydroxydopamine-induced Parkinson’s Disease in Rats. Annals of Neurosciences. 31(3). 186–203. 3 indexed citations
3.
Pal, Rishi, et al.. (2023). Modulation of Autophagy and Nitric Oxide Signaling via Glycyrrhizic Acid and 7-Nitroindazole in MPTP-induced Parkinson’s Disease Model. Annals of Neurosciences. 31(4). 265–276. 1 indexed citations
4.
Tiwari, Prafulla, et al.. (2022). Effects of mangiferin and its combination with nNOS inhibitor 7‐nitro‐indazole (7‐NI) in 6‐hydroxydopamine (6‐OHDA) lesioned Parkinson's disease rats. Fundamental and Clinical Pharmacology. 36(6). 944–955. 5 indexed citations
5.
Akhtar, Mohd Javed, Sarvesh Kumar Singh, Ajay Kumar Verma, Rishi Pal, & Rajendra Nath. (2021). A prospective observational study to evaluate Glutathione S-transferase gene polymorphism and its association with Antitubercular drugs induced liver injury in tertiary hospital. Indian Journal of Tuberculosis. 69(3). 341–346. 2 indexed citations
6.
Vats, Monika, et al.. (2020). Synthesis and biological evaluation of imidazoline derivatives as potential CNS and CVS agents. Bioorganic & Medicinal Chemistry Letters. 30(23). 127595–127595. 3 indexed citations
7.
Yadav, Suraj Singh, et al.. (2020). No Association Between a Genetic Variant of FOXO3 and Risk of Type 2 Diabetes Mellitus in the Elderly Population of North India. Indian Journal of Clinical Biochemistry. 36(3). 330–336. 1 indexed citations
8.
9.
Nath, Rajendra, et al.. (2017). An experimental study to see the antihypertensive effects of gymnema sylvestre and acorus calamus in wistar rats and its comparison with amlodipine. SHILAP Revista de lepidopterología. 8(3). 11–15. 2 indexed citations
10.
Singh, Pramod Kumar, et al.. (2017). Attenuation of Lead-Induced Neurotoxicity by Omega-3 Fatty Acid in Rats. Annals of Neurosciences. 24(4). 221–232. 28 indexed citations
11.
12.
Nath, Rajendra, Kauser Usman, Sanjay Khattri, et al.. (2015). Effects of a standardized Ayurvedic formulation on diabetes control in newly diagnosed Type-2 diabetics; a randomized active controlled clinical study. Complementary Therapies in Medicine. 23(4). 555–561. 19 indexed citations
13.
Pathak, Seema R., et al.. (2014). Synthesis and Antihypertensive Activity of Novel Quinazolin-4(3H)-one Derivatives. Central Nervous System Agents in Medicinal Chemistry. 14(1). 34–38. 16 indexed citations
14.
Ginsberg, Gary, Babasaheb Sonawane, Rajendra Nath, & Paul Lewandowski. (2014). Methylmercury-Induced Inhibition of Paraoxonase-1 (PON1)—Implications for Cardiovascular Risk. Journal of Toxicology and Environmental Health. 77(17). 1004–1023. 20 indexed citations
15.
Nath, Rajendra, et al.. (2014). Molecular Docking studies of D2 Dopamine receptor with Risperidone derivatives. Bioinformation. 10(1). 8–12. 9 indexed citations
16.
Gupta, Sunil Kumar, et al.. (2012). Design of potential siRNA molecules for hepatitis delta virus gene silencing. Bioinformation. 8(16). 749–757. 20 indexed citations
17.
Gupta, Sunil Kumar, Anuradha Nischal, Sanjay Khattri, et al.. (2011). Identification and Characterization of Novel Small-Molecule Inhibitors against Hepatitis Delta Virus Replication by Using Docking Strategies. Hepatitis Monthly. 11(10). 803–809. 5 indexed citations
18.
Pathak, Seema R., et al.. (2010). Substituted imidazole derivatives as novel cardiovascular agents. Bioorganic & Medicinal Chemistry Letters. 21(3). 936–939. 19 indexed citations
19.
Pant, Kamlesh Kumar, et al.. (2008). PARFLEX--a very useful drug for management of surgical pain.. PubMed. 106(6). 409–11. 1 indexed citations
20.
Pathak, Seema R., et al.. (2002). Substituted pyrazolines and their cardiovascular activity. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 41(6). 1310–1313. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mahmoud Balbaa Breakdown of academic impact, for papers by Lohanathan Bharathi Priya Breakdown of academic impact, for papers by Rainer Ziegenhagen Breakdown of academic impact, for papers by Shiva Roshankhah Breakdown of academic impact, for papers by G. Smilin Bell Aseervatham Breakdown of academic impact, for papers by Ashfaq Ahmad Breakdown of academic impact, for papers by T. Balakrishna Poduval Breakdown of academic impact, for papers by Fatma Göçer Breakdown of academic impact, for papers by Incoronata Laurenza Breakdown of academic impact, for papers by P. L. Vijayammal
Rankless by CCL
2026